IP Library Granted Patent US 8,101,767
Granted Patent B2
US 8,101,767 · App. 12/351,401 · Granted Jan 24, 2012

Modulators of ATP-binding cassette transporters

Assignee: Vertex Pharmaceuticals Incorporated
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,101,767
App. No.
12/351,401
Granted
Jan 24, 2012
Kind
B2
Abstract

The present invention relates to modulators of ATP-Binding Cassette (“ABC”) transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator, compositions thereof, and methods therewith. The present invention also relates to methods of treating ABC transporter mediated diseases using such modulators.

Claims (238)

1. A compound of formula V-B-5:

wherein:

ring A 2 is a phenyl or a 5-6 membered heteroaryl ring, wherein ring A 2 and the phenyl ring fused thereto together have up 4 substituents independently selected from WR W ; and

W is a bond or is an optionally substituted C 1 -C 6 alkylidene chain wherein up to two methylene units of W are optionally and independently replaced by —CO—, —CS—, —COCO—, —CONR′—, —CONR′NR′—, —CO 2 —, —OCO—, —NR′CO 2 —, —O—, —NR′CONR′—, —OCONR′—, —NR′NR′, —NR′NR′CO—, —NR′CO—, —S—, —SO, —SO 2 —, —NR′—, —SO 2 NR′—, NR′SO 2 —, —NR′SO 2 NR′—;

R W is independently R′, halo, NO 2 , CN, CF 3 , or OCF 3 ;

X is a bond or is an optionally substituted C 1 -C 6 alkylidene chain wherein up to two methylene units of X are optionally and independently replaced by —CO—, —CS—, —COCO—,—CONR′—, —CONR′NR′—, —CO 2 —, —OCO—, —NR′CO 2 —, —O—, —NR′CONR′—, —OCONR′—, —NR′NR′, —NR′NR′CO—, —NR′CO—, —S—, —SO, —SO 2 —,—NR′—, —SO 2 NR′—, NR′SO 2 —, or —NR′SO 2 NR′—;

R X is independently R′, halo, NO 2 , CN, CF 3 , or OCF 3 ;

R′ is independently selected from hydrogen or an optionally substituted group selected from a C 1 -C 8 aliphatic group a 3-8-membered saturated, partially unsaturated, or fully unsaturated monocyclic ring having 0-3 heteroatoms independently selected from nitrogen, oxygen, or sulfur, or an 8-12 membered saturated, partially unsaturated, or fully unsaturated bicyclic ring system having 0-5 heteroatoms independently selected from nitrogen, oxygen, or sulfur; or two occurrences of R′ are taken together with the atom(s) to which they are bound to form an optionally substituted 3-12 membered saturated, partially unsaturated, or fully unsaturated monocyclic or bicyclic ring having 0-4 heteroatoms independently selected from nitrogen, oxygen, or sulfur; and

m is 0-4.

2. The compound according to claim 1 , wherein ring A 2 is selected from:

wherein said ring is optionally substituted.

3. The compound according to claim 1 , wherein said compound has formula V-B-5-a:

wherein:

G 4 is hydrogen, halo, CN, CF 3 , CHF 2 , CH 2 F, optionally substituted C1-C6 aliphatic, aryl-C1-C6 alkyl, or a phenyl, wherein G 4 is optionally substituted with up to 4 WR W substituents; wherein up to two methylene units of said C1-C6 aliphatic or C1-C6 alkyl is optionally replaced with —CO—, —CONR′—, —CO 2 —, —OCO—, —NR′CO 2 —, —O—, —NR′CONR′—, —OCONR′—, —NR′CO—, —S—, —NR′—, —SO 2 NR′—, NR′SO 2 —, or —NR′SO 2 NR′—;

G 5 is hydrogen or an optionally substituted C1-C6 aliphatic;

wherein said indole ring system is further optionally substituted with up to 3 substituents independently selected from WR W .

4. The compound according to claim 3 , wherein G 4 is hydrogen, and G 5 is C1-C6 aliphatic, wherein said aliphatic is optionally substituted with C1-C6 alkyl, halo, cyano, or CF 3 , and wherein up to two methylene units of said C1-C6 aliphatic or C1-C6 alkyl is optionally replaced with —CO—, —CONR′—, —CO 2 —, —OCO—, —NR′CO 2 —, —O—, —NR′CONR′—, —OCONR′—, —NR′CO—, —S—, —NR′—, —SO 2 NR′—, NR′SO 2 —, or —NR′SO 2 NR′—.

5. The compound according to claim 3 , wherein G 4 is hydrogen, and G 5 is cyano, methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, t-butyl, cyanomethyl, methoxyethyl, CH 2 C(O)OMe, (CH 2 ) 2 —NHC(O)O-tert-But, or cyclopentyl.

6. The compound according to claim 3 , wherein G 5 is hydrogen, and G 4 is halo, C1-C6 aliphatic or phenyl, wherein said aliphatic or phenyl is optionally substituted with C1-C6 alkyl, halo, cyano, or CF 3 , wherein up to two methylene units of said C1-C6 aliphatic or C1-C6 alkyl is optionally replaced with —CO—, —CONR′—, —CO 2 —, —OCO—, —NR′CO 2 —, —O—, —NR′CONR′—, —OCONR′—, —NR′CO—, —S—, —NR′—, —SO 2 NR′—, NR′SO 2 —, or —NR′SO 2 NR′—.

7. The compound according to claim 3 , wherein G 5 is hydrogen, and G 4 is halo, ethoxycarbonyl, t-butyl, 2-methoxyphenyl, 2-ethoxyphenyl, (4-C(O)NH(CH 2 ) 2 —NMe 2 )-phenyl, 2-methoxy-4-chloro-phenyl, pyridine-3-yl, 4-isopropylphenyl, 2,6-dimethoxyphenyl, sec-butylaminocarbonyl, ethyl, t-butyl, or piperidin-1-ylcarbonyl.

8. A compound selected from:

Cmpd

No.

Name

1

N-[5-(5-chloro-2-methoxy-phenyl)-1H-indol-6-yl]-4-oxo-1H-quinoline-3-carboxamide

22

4-Oxo-1,4-dihydro-quinoline-3-carboxylic acid N-(1′,2′-dihydrospiro[cyclopropane-1,3′-

[3H]indol]-6′-yl)-amide

27

N-[1-[2-[methyl-(2-methylaminoacetyl)-amino]acetyl]-1H-indol-6-yl]-4-oxo-1H-

quinoline-3-carboxamide

32

N-(5-chloro-1H-indol-6-yl)-4-oxo-1H-quinoline-3-carboxamide

33

N-(1H-indol-6-yl)-4-oxo-1H-quinoline-3-carboxamide

37

N-(1H-indol-7-yl)-4-oxo-1H-quinoline-3-carboxamide

44

N-(2-methylbenzothiazol-5-yl)-4-oxo-1H-quinoline-3-carboxamide

51

6-[(4-methyl-1-piperidyl)sulfonyl]-4-oxo-N-(5-tert-butyl-1H-indol-6-yl)-1H-quinoline-

3-carboxamide

54

4-oxo-N-(8-thia-7,9-diazabicyclo[4.3.0]nona-2,4,6,9-tetraen-5-yl)-1H-quinoline-3-

carboxamide

64

4-oxo-N-(2-oxo-1,3-dihydrobenzoimidazol-5-yl)-1H-quinoline-3-carboxamide

65

4-oxo-N-[5-(3-pyridyl)-1H-indol-6-yl]-1H-quinoline-3-carboxamide

66

N-(2,2-difluorobenzo[1,3]dioxol-5-yl)-4-oxo-1H-quinoline-3-carboxamide

67

6-ethyl-4-hydroxy-N-(1H-indol-6-yl)quinoline-3-carboxamide

73

4-oxo-N-(2-phenyl-3H-benzoimidazol-5-yl)-1H-quinoline-3-carboxamide

77

N-(5-fluoro-1H-indol-6-yl)-4-oxo-1H-quinoline-3-carboxamide

96

N-[3-(cyanomethyl)-1H-indol-6-yl]-4-oxo-1H-quinoline-3-carboxamide

100

N-(1H-indol-4-yl)-4-oxo-1H-quinoline-3-carboxamide

104

N-(2-methyl-1H-indol-6-yl)-4-oxo-1H-quinoline-3-carboxamide

105

1,4-dihydro-N-(3,4-dihydro-2H-benzo[b][1,4]oxazin-6-yl)-4-oxoquinoline-3-

carboxamide

107

7-[(4-oxo-1H-quinolin-3-yl)carbonylamino]-1,2,3,4-tetrahydroisoquinoline-2-carboxylic

acid tert-butyl ester

108

4,4-dimethyl-7-[(4-oxo-1H-quinoline-3-yl)carbonylamino]-1,2,3,4-tetrahydroquinoline-

1-carboxylic acid tert-butyl ester

112

6-ethoxy-4-hydroxy-N-(1H-indol-6-yl)quinoline-3-carboxamide

113

N-(3-methyl-1H-indol-6-yl)-4-oxo-1H-quinoline-3-carboxamide

116

5-hydroxy-N-(1H-indol-6-yl)-4-oxo-1H-quinoline-3-carboxamide

124

6-fluoro-4-oxo-N-(5-tert-butyl-1H-indol-6-yl)-1H-quinoline-3-carboxamide

130

4-hydroxy-N-(1H-indol-6-yl)-5,7-bis(trifluoromethyl)quinoline-3-carboxamide

145

6-[(4-oxo-1H-quinolin-3-yl)carbonylamino]-1H-indole-4-carboxylic acid ethyl ester

146

4-oxo-N-(1,7,9-triazabicyclo[4.3.0]nona-2,4,6,8-tetraen-5-yl)-1H-quinoline-3-

carboxamide

148

4-oxo-N-[5-(1-piperidylcarbonyl)-1H-indol-6-yl]-1H-quinoline-3-carboxamide

152

4-oxo-N-(2-oxo-3H-benzooxazol-6-yl)-1H-quinoline-3-carboxamide

158

4-oxo-N-(5-phenyl-1H-indol-6-yl)-1H-quinoline-3-carboxamide

169

N-(1-methyl-1H-indol-6-yl)-4-oxo-1H-quinoline-3-carboxamide

175

4-Oxo-1,4-dihydro-quinoline-3-carboxylic acid N-(1′-Acetyl-1′,2′-

dihydrospiro[cyclopropane-1,3′-3H-indol]-6′-yl)-amide

183

7-[(4-oxo-1H-quinolin-3-yl)carbonylamino]-1,2,3,4-tetrahydroquinoline-1-carboxylic

acid tert-butyl ester

184

N-(1H-indol-6-yl)-4-oxo-2-(trifluoromethyl)-1H-quinoline-3-carboxamide

186

N-(3-cyclopentyl-1H-indol-6-yl)-4-oxo-1H-quinoline-3-carboxamide

187

N-(1-acetyl-1H-indol-6-yl)-4-oxo-1H-quinoline-3-carboxamide

188

6-[(4-oxo-1H-quinolin-3-yl)carbonylamino]-1H-indole-5-carboxylic acid ethyl ester

191

4-oxo-N-(5-quinolyl)-1H-quinoline-3-carboxamide

203

N-(1-benzyl-1H-indol-6-yl)-4-oxo-1H-quinoline-3-carboxamide

204

N-(4,4-dimethylchroman-7-yl)-4-oxo-1H-quinoline-3-carboxamide

207

2-[6-[(4-oxo-1H-quinolin-3-yl)carbonylamino]-1H-indol-3-yl]acetic acid ethyl ester

216

N-(3H-benzoimidazol-2-yl)-4-oxo-1H-quinoline-3-carboxamide

217

N-(1H-indazol-5-yl)-4-oxo-1H-quinoline-3-carboxamide

230

N-(2-methyl-1H-indol-5-yl)-4-oxo-1H-quinoline-3-carboxamide

233

N-(1-acetylindolin-6-yl)-4-oxo-1H-quinoline-3-carboxamide

234

4-oxo-N-[5-(trifluoromethyl)-1H-indol-6-yl]-1H-quinoline-3-carboxamide

237

N-[5-(2-methoxyphenyl)-1H-indol-6-yl]-4-oxo-1H-quinoline-3-carboxamide

238

7′-[(4-oxo-1H-quinolin-3-ylcarbonyl)amino]-spiro[piperidine-4,4′(1′H)-quinoline], 2′,3′-

dihydro-carboxylic acid tert-butyl ester

241

4-oxo-N-(8-quinolyl)-1H-quinoline-3-carboxamide

244

4-oxo-N-(6,7,8,9-tetrahydro-5H-carbazol-2-yl)-1H-quinoline-3-carboxamide

254

6-fluoro-N-(5-fluoro-1H-indol-6-yl)-4-oxo-1H-quinoline-3-carboxamide

256

N-(1H-benzotriazol-5-yl)-4-oxo-1H-quinoline-3-carboxamide

258

N-indolin-6-yl-4-oxo-1H-quinoline-3-carboxamide

259

4-oxo-N-(3-sec-butyl-1H-indol-6-yl)-1H-quinoline-3-carboxamide

262

1,4-dihydro-N-(3,4-dihydro-3-oxo-2H-benzo[b][1,4]thiazin-6-yl)-4-oxoquinoline-3-

carboxamide

270

N-(2-cyano-1H-indol-6-yl)-4-oxo-1H-quinoline-3-carboxamide

274

4-oxo-6-pyrrolidin-1-ylsulfonyl-N-(5-tert-butyl-1H-indol-6-yl)-1H-quinoline-3-

carboxamide

280

4-oxo-N-(6-quinolyl)-1H-quinoline-3-carboxamide

284

N-(1H-indazol-6-yl)-4-oxo-1H-quinoline-3-carboxamide

294

N-(1H-indol-5-yl)-4-oxo-1H-quinoline-3-carboxamide

299

4-oxo-N-(1,2,3,4-tetrahydroquinolin-7-yl)-1H-quinoline-3-carboxamide

300

N-(4,4-dimethyl-1,2,3,4-tetrahydroquinolin-7-yl)-4-oxo-1H-quinoline-3-carboxamide

303

N-(2-acetyl-1,2,3,4-tetrahydroisoquinolin-7-yl)-4-oxo-1H-quinoline-3-carboxamide

320

4-oxo-N-(2-tert-butyl-1H-indol-6-yl)-1H-quinoline-3-carboxamide

327

N-[5-(2-ethoxyphenyl)-1H-indol-6-yl]-4-oxo-1H-quinoline-3-carboxamide

329

N-[2-(o-tolyl)benzooxazol-5-yl]-4-oxo-1H-quinoline-3-carboxamide

334

7′-[(4-oxo-1H-quinolin-3-ylcarbonyl)amino]-spiro[piperidine-4,4′(1′H)-1-acetyl-

quinoline], 2′,3′-dihydro-carboxylic acid tert-butyl ester

338

N-(3-methyl-1H-indol-4-yl)-4-oxo-1H-quinoline-3-carboxamide

339

N-(3-cyano-1H-indol-6-yl)-4-oxo-1H-quinoline-3-carboxamide

342

N-[5-(4-isopropylphenyl)-1H-indol-6-yl]-4-oxo-1H-quinoline-3-carboxamide

343

N-[5-(isobutylcarbamoyl)-1H-indol-6-yl]-4-oxo-1H-quinoline-3-carboxamide

345

6-fluoro-4-hydroxy-N-(1H-indol-6-yl)quinoline-3-carboxamide

347

N-[5-[4-(2-dimethylaminoethylcarbamoyl)phenyl]-1H-indol-6-yl]-4-oxo-1H-quinoline-

3-carboxamide

351

N-(5-ethyl-1H-indol-6-yl)-4-oxo-1H-quinoline-3-carboxamide

352

2-[6-[(4-oxo-1H-quinolin-3-yl)carbonylamino]-1H-indol-3-yl]ethylaminoformic acid

tert-butyl ester

357

N-(3-isopropyl-1H-indol-6-yl)-4-oxo-1H-quinoline-3-carboxamide

358

6-chloro-4-hydroxy-N-(1H-indol-6-yl)quinoline-3-carboxamide

364

N-(2-methyl-8-quinolyl)-4-oxo-1H-quinoline-3-carboxamide

374

4-hydroxy-N-(1H-indol-6-yl)-2-methylsulfanyl-quinoline-3-carboxamide

376

4-oxo-N-(2-phenylbenzooxazol-5-yl)-1H-quinoline-3-carboxamide

377

6,8-difluoro-4-hydroxy-N-(1H-indol-6-yl)quinoline-3-carboxamide

381

4-oxo-N-(5-tert-butyl-1H-indol-6-yl)-1H-quinoline-3-carboxamide

383

N-(3-ethyl-1H-indol-6-yl)-4-oxo-1H-quinoline-3-carboxamide

386

N-(3,3-dimethylindolin-6-yl)-4-oxo-1H-quinoline-3-carboxamide

404

N-[5-(2,6-dimethoxyphenyl)-1H-indol-6-yl]-4-oxo-1H-quinoline-3-carboxamide

406

6-[(4-fluorophenyl)-methyl-sulfamoyl]-4-oxo-N-(5-tert-butyl-1H-indol-6-yl)-1H-

quinoline-3-carboxamide

412

6-[(4-oxo-1H-quinolin-3-yl)carbonylamino]-1H-indole-7-carboxylic acid ethyl ester

414

N-(3H-benzoimidazol-5-yl)-4-oxo-1H-quinoline-3-carboxamide

423

N-[3-(2-ethoxyethyl)-1H-indol-6-yl]-4-oxo-1H-quinoline-3-carboxamide

427

5-[(4-oxo-1H-quinolin-3-yl)carbonylamino]-1,2,3,4-tetrahydroisoquinoline-2-carboxylic

acid tert-butyl ester

437

N-benzo[1,3]dioxol-5-yl-4-oxo-1H-quinoline-3-carboxamide

443

4-oxo-N-quinoxalin-6-yl-1H-quinoline-3-carboxamide

446

N-(1,1-dioxobenzothiophen-6-yl)-4-oxo-1H-quinoline-3-carboxamide

467

N-(2,3-dihydrobenzofuran-5-yl)-4-oxo-1H-quinoline-3-carboxamide

474

N-(3-methyl-2-oxo-3H-benzooxazol-5-yl)-4-oxo-1H-quinoline-3-carboxamide

478

4-oxo-N-(3-tert-butyl-1H-indol-6-yl)-1H-quinoline-3-carboxamide

479

N-(1H-indol-6-yl)-5-methoxy-4-oxo-1H-quinoline-3-carboxamide.

Assignments (4)
RELEASE OF SECURITY INTEREST Recorded Oct 14, 2016
From: MACQUARIE US TRADING LLC
To: VERTEX PHARMACEUTICALS INCORPORATED; VERTEX PHARMACEUTICALS (SAN DIEGO) LLC
Reel/Frame 040357/0001 →
ASSIGNEE CHANGE OF ADDRESS Recorded Feb 17, 2016
From: VERTEX PHARMACEUTICALS INCORPORATED
To: VERTEX PHARMACEUTICALS INCORPORATED
Reel/Frame 037841/0274 →
SECURITY INTEREST Recorded Jul 10, 2014
From: VERTEX PHARMACEUTICALS INCORPORATED; VERTEX PHARMACEUTICALS (SAN DIEGO) LLC
To: MACQUARIE US TRADING LLC
Reel/Frame 033292/0311 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 21, 2012
From: HADIDA-RUAH, SARA; HAZELWOOD, ANNA; GROOTENHUIS, PETER; VAN GOOR, FREDRICK; SINGH, ASHVANI; ZHOU, JINGLAN; MCCARTNEY, JASON
To: VERTEX PHARMACEUTICALS INCORPORATED
Reel/Frame 027736/0474 →
Continuity (7)
Continuation 11165818 · Jun 24, 2005
Provisional Application 60582676 · Jun 24, 2004
Provisional Application 60630127 · Nov 22, 2004
Provisional Application 60635674 · Dec 13, 2004
Provisional Application 60658219 · Mar 3, 2005
Provisional Application 60661311 · Mar 11, 2005
Related Publication 20090227797A1 · Sep 10, 2009